Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Molecules ; 28(2)2023 Jan 14.
Artigo em Inglês | MEDLINE | ID: mdl-36677913

RESUMO

A concise review covering updated presence and role of 2-phenethylamines in medicinal chemistry is presented. Open-chain, flexible alicyclic amine derivatives of this motif are enumerated in key therapeutic targets, listing medicinal chemistry hits and appealing screening compounds. Latest reports in discovering new bioactive 2-phenethylamines by research groups are covered too.


Assuntos
Química Farmacêutica , Receptores Acoplados a Proteínas G , Fenetilaminas/farmacologia , Fenetilaminas/química , Receptores de Dopamina D2
2.
Molecules ; 26(11)2021 May 22.
Artigo em Inglês | MEDLINE | ID: mdl-34067439

RESUMO

Ezetimibe is a well-known drug that lowers blood cholesterol levels by reducing its absorption in the small intestine when joining to Niemann-Pick C1-like protein (NPC1L1). A ligand-based study on ezetimibe analogues is reported, together with one-hit synthesis, highlighted in the study. A convenient asymmetric synthesis of (2S,3S)-N-α-(R)-methylbenzyl-3-methoxycarbonylethyl-4-methoxyphenyl ß-lactam is described starting from Baylis-Hillman adducts. The route involves a domino process: allylic acetate rearrangement, stereoselective Ireland-Claisen rearrangement and asymmetric Michael addition, which provides a δ-amino acid derivative with full stereochemical control. A subsequent inversion of ester and acid functionality paves the way to the lactam core after monodebenzylation and lactam formation. It also shows interesting results when it comes to a pharmacophore study based on ezetimibe as the main ligand in lowering blood cholesterol levels, revealing which substituents on the azetidine-2-one ring are more similar to the ezetimibe skeleton and will more likely bind to NPC1L1 than ezetimibe.


Assuntos
Técnicas de Química Sintética , Desenho de Fármacos , Ezetimiba/análogos & derivados , Ezetimiba/síntese química , Alelos , Amidas/química , Aminoácidos/química , Anticolesterolemiantes/administração & dosagem , Anticolesterolemiantes/síntese química , Colesterol/sangue , Humanos , Ligantes , Espectroscopia de Ressonância Magnética , Proteínas de Membrana Transportadoras/metabolismo , Simulação de Acoplamento Molecular , Piridinas/química , Estereoisomerismo
3.
Eur J Med Chem ; 101: 150-62, 2015 Aug 28.
Artigo em Inglês | MEDLINE | ID: mdl-26134550

RESUMO

Structure-Activity Relationship (SAR) is a current approach in the design of new pharmacological agents. We previously reported the synthesis of a novel analogue of morphine, a 2-azabicyclo[3.3.1]nonane, which contains a ß-amino acid. This bicyclic core exhibits two distinctive chemical handles for further elaboration, which allowed us to create a library of morphan-containing compounds by in silico molecular docking on the µ opioid receptor. Lead candidates were synthesized and biological tests were performed to evaluate their ability to bind to opioid receptors. The four top compounds, three phenyl esters and an N-phenylethyl morphan derivative, were selected for Molecular Dynamics simulations to get topological and thermodynamic information. Aromatic morphan derivatives displayed an interacting domain which fits into a hydrophobic cleft and the effect of the substituents in their affinity was explained by the differences in the calculated binding free energies. Our results indicate that the 3D arrangement of the aromatic ring in the morphine derivatives is not a key issue for a specific ligand - µ receptor interaction. Thus, these morphan derivatives represent a new class of opioid receptor ligands which may be of great use in the clinical practice.


Assuntos
Aminoácidos/química , Desenho de Fármacos , Simulação de Dinâmica Molecular , Morfinanos/química , Morfinanos/metabolismo , Receptores Opioides mu/metabolismo , Relação Dose-Resposta a Droga , Humanos , Ligantes , Estrutura Molecular , Morfinanos/síntese química , Receptores Opioides mu/química , Relação Estrutura-Atividade
4.
J Comput Chem ; 35(25): 1846-53, 2014 Sep 30.
Artigo em Inglês | MEDLINE | ID: mdl-25052741

RESUMO

The asymmetric Aza-Michael addition of homochiral lithium benzylamides to α,ß-unsaturated esters represents an extended protocol to obtain enantioenriched ß-amino esters. An exhaustive mechanistic revision of the originally proposed mechanism is reported, developing a quantum mechanics/molecular mechanics protocol for the asymmetric Aza-Michael reaction of homochiral lithium benzylamides. Explicit and implicit solvent schemes were considered, together with a proper account of long-range dispersion forces, evaluated through a density functional theory benchmark of different functionals. Theoretical results showed that the diastereoselectivity is mainly controlled by the N-α-methylbenzyl moiety placing, deriving a Si/Re 99:1 diastereoselective ratio, in good agreement with reported experimental results. The main transition state geometries are two transition state conformers in a "V-stacked" orientation of the amide's phenyl rings, differing in the tetrahydrofuran molecule arrangement coordinated to the metal center. Extensive conformational sampling and quantum-level refinement give reasonable good speed/accuracy results, allowing this protocol to be extended to other similar Aza-Michael reaction systems.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...